QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
The
|
Large accelerated filer
|
☐
|
|
☒
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
Page
|
||
PART I.
|
3
|
|
Item 1.
|
3
|
|
3
|
||
4
|
||
6
|
||
7
|
||
8
|
||
Item 2.
|
27
|
|
Item 3.
|
47
|
|
Item 4.
|
47
|
|
PART II.
|
48
|
|
Item 1.
|
48
|
|
Item 1A.
|
48
|
|
Item 2.
|
48
|
|
Item 3.
|
48
|
|
Item 4.
|
48
|
|
Item 5.
|
48
|
|
Item 6.
|
49
|
|
50
|
March 31,
2024
|
December 31,
2023
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Cash and due from banks
|
$
|
|
$
|
|
||||
Interest-bearing deposits in banks
|
|
|
||||||
Cash and cash equivalents
|
|
|
||||||
Securities available for sale
|
|
|
||||||
Loans held for sale ($
|
|
|
||||||
Loans held for investment
|
|
|
||||||
Allowance for credit losses on loans
|
(
|
)
|
(
|
)
|
||||
Loans held for investment, net
|
||||||||
Accrued interest receivable
|
|
|
||||||
Premises and equipment, net
|
|
|
||||||
Bank-owned life insurance
|
|
|
||||||
Goodwill
|
|
|
||||||
Intangible assets, net
|
|
|
||||||
Mortgage servicing rights
|
|
|
||||||
Deferred tax asset, net
|
|
|
||||||
Other assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Deposits:
|
||||||||
Noninterest-bearing
|
$
|
|
$
|
|
||||
Interest-bearing
|
|
|
||||||
Total deposits
|
|
|
||||||
Accrued expenses and other liabilities
|
|
|
||||||
Subordinated debt
|
|
|
||||||
Junior subordinated deferrable interest debentures
|
|
|
||||||
Total liabilities
|
|
|
||||||
Stockholders’ equity:
|
||||||||
Common stock, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Total stockholders’ equity
|
|
|
||||||
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
Three Months Ended
March 31,
|
||||||||
2024
|
2023
|
|||||||
Interest income:
|
||||||||
Loans, including fees
|
$
|
|
$
|
|
||||
Securities:
|
||||||||
Taxable
|
|
|
||||||
Non-taxable
|
|
|
||||||
Federal funds sold and interest-bearing deposits in banks
|
|
|
||||||
Total interest income
|
|
|
||||||
Interest expense:
|
||||||||
Deposits
|
|
|
||||||
Subordinated debt
|
|
|
||||||
Junior subordinated deferrable interest debentures
|
|
|
||||||
Total interest expense
|
|
|
||||||
Net interest income
|
|
|
||||||
Provision for credit losses
|
|
|
||||||
Net interest income, after provision for credit losses
|
|
|
||||||
Noninterest income:
|
||||||||
Service charges on deposit accounts
|
|
|
||||||
Income from insurance activities
|
|
|
||||||
Net gain on sales of loans
|
|
|
||||||
Bank card services and interchange fees
|
|
|
||||||
Other mortgage banking income (loss)
|
( |
) | ||||||
Investment commissions
|
|
|
||||||
Fiduciary fees
|
|
|
||||||
Other
|
|
|
||||||
Total noninterest income
|
|
|
||||||
Noninterest expense:
|
||||||||
Salaries and employee benefits
|
|
|
||||||
Occupancy and equipment, net
|
|
|
||||||
Professional services
|
|
|
||||||
Marketing and development
|
|
|
||||||
IT and data services
|
|
|
||||||
Bank card expenses
|
|
|
||||||
Appraisal expenses
|
|
|
||||||
Other
|
|
|
||||||
Total noninterest expense
|
|
|
||||||
Income before income taxes
|
|
|
||||||
Income tax expense
|
|
|
||||||
Net income
|
$
|
|
$
|
|
Three Months Ended
March 31,
|
||||||||
2024
|
2023
|
|||||||
Earnings per share:
|
||||||||
Basic
|
$
|
|
$
|
|
||||
Diluted
|
$
|
|
$
|
|
||||
Net income
|
$
|
|
$
|
|
||||
Other comprehensive income (loss):
|
||||||||
Unrealized gains (losses) on securities available for sale
|
(
|
)
|
|
|||||
Less: Change in fair value on hedged state and municipal securities
|
|
(
|
)
|
|||||
Tax effect
|
|
(
|
)
|
|||||
Other comprehensive income (loss)
|
(
|
)
|
|
|||||
Comprehensive income
|
$
|
|
$
|
|
Common Stock
|
Additional
Paid-in
|
Retained
|
Accumulated
Other
Comprehensive
|
|||||||||||||||||||||
Shares
|
Amount
|
Capital
|
Earnings
|
Income (Loss)
|
Total
|
|||||||||||||||||||
Three Months Ended March 31, 2023
|
||||||||||||||||||||||||
Balance at beginning of period
|
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||
Net income
|
— | |||||||||||||||||||||||
Cash dividends declared - $
|
— | ( |
) | ( |
) | |||||||||||||||||||
Other comprehensive income
|
— | |||||||||||||||||||||||
Impact of adoption of ASU 2016-13 - CECL
|
— | ( |
) | ( |
) | |||||||||||||||||||
Exercise of employee stock options and vesting of restricted stock units, net of
|
( |
) | ( |
) | ||||||||||||||||||||
Stock-based compensation
|
— | |||||||||||||||||||||||
Balance at end of period
|
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||
Balance at beginning of period
|
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||
Net income
|
— | |||||||||||||||||||||||
Cash dividends declared - $
|
— | ( |
) | ( |
) | |||||||||||||||||||
Other comprehensive loss
|
— | ( |
) | ( |
) | |||||||||||||||||||
Exercise of employee stock options and vesting of restricted stock units, net of
|
( |
) | ( |
) | ||||||||||||||||||||
Repurchases of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Stock-based compensation
|
— | |||||||||||||||||||||||
Balance at end of period
|
$ | $ | $ | $ | ( |
) | $ |
Three Months Ended
March 31,
|
||||||||
2024
|
2023
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash from operating activities:
|
||||||||
Provision for credit losses
|
|
|
||||||
Depreciation and amortization
|
|
|
||||||
Accretion and amortization
|
|
|
||||||
Other gains, net
|
|
(
|
)
|
|||||
Net gain on sales of loans
|
(
|
)
|
(
|
)
|
||||
Proceeds from sales of loans held for sale
|
|
|
||||||
Loans originated for sale
|
(
|
)
|
(
|
)
|
||||
Deferred income tax expense
|
||||||||
Earnings on bank-owned life insurance
|
(
|
)
|
(
|
)
|
||||
Stock-based compensation
|
|
|
||||||
Change in valuation of mortgage servicing rights
|
(
|
)
|
|
|||||
Net change in:
|
||||||||
Accrued interest receivable and other assets
|
|
|
||||||
Accrued expenses and other liabilities
|
|
(
|
)
|
|||||
Net cash provided by operating activities
|
|
|
||||||
Cash flows from investing activities:
|
||||||||
Activity in securities available for sale:
|
||||||||
Purchases
|
(
|
)
|
|
|||||
Maturities, prepayments, and calls
|
|
|
||||||
Loan originations and principal collections, net
|
|
(
|
)
|
|||||
Purchases of premises and equipment
|
(
|
)
|
(
|
)
|
||||
Proceeds from sales of premises and equipment
|
|
|
||||||
Proceeds from sales of foreclosed assets
|
|
|
||||||
Net cash provided by (used in) investing activities
|
|
(
|
)
|
|||||
Cash flows from financing activities:
|
||||||||
Net change in deposits
|
|
|
||||||
Payments to tax authorities for stock-based compensation
|
(
|
)
|
(
|
)
|
||||
Cash dividends paid on common stock
|
(
|
)
|
(
|
)
|
||||
Payments to repurchase common stock
|
(
|
)
|
|
|||||
Net cash provided by financing activities
|
|
|
||||||
Net change in cash and cash equivalents
|
|
|
||||||
Beginning cash and cash equivalents
|
|
|
||||||
Ending cash and cash equivalents
|
$
|
|
$
|
|
||||
Supplemental disclosures of cash flow information:
|
||||||||
Interest paid on deposits and borrowed funds
|
$
|
|
$
|
|
||||
Income taxes paid
|
||||||||
Supplemental schedule of noncash activities:
|
||||||||
Loans transferred to foreclosed assets
|
$
|
|
$
|
|
||||
Additions to mortgage servicing rights
|
|
|
Wholly-Owned, Consolidated Subsidiaries:
|
|
|
Bank subsidiary
|
|
Non-bank subsidiary
|
|
Non-bank subsidiary
|
|
Non-bank subsidiary
|
|
Non-bank subsidiary
|
Wholly-Owned, Equity Method Subsidiaries:
|
|
|
Non-bank subsidiaries
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Allowance
for Credit
Losses
|
Fair
Value
|
||||||||||||||||
March 31, 2024
|
||||||||||||||||||||
Available for sale:
|
||||||||||||||||||||
State and municipal
|
$
|
|
$
|
|
$
|
(
|
)
|
$ |
$
|
|
||||||||||
Residential mortgage-backed
securities
|
( |
) | ||||||||||||||||||
Commercial mortgage-backed securities
|
( |
) | ||||||||||||||||||
Commercial collateralized mortgage obligations
|
|
|
(
|
)
|
|
|||||||||||||||
Asset-backed and other amortizing securities
|
|
|
(
|
)
|
|
|||||||||||||||
Other securities
|
|
|
(
|
)
|
|
|||||||||||||||
$
|
|
$
|
|
$
|
(
|
)
|
$ |
$
|
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Allowance
for Credit
Losses
|
Fair
Value
|
||||||||||||||||
December 31, 2023
|
||||||||||||||||||||
Available for sale:
|
||||||||||||||||||||
State and municipal
|
$
|
|
$
|
|
$
|
(
|
)
|
$ |
$
|
|
||||||||||
Residential mortgage-backed securities
|
( |
) | ||||||||||||||||||
Commercial mortgage-backed securities
|
( |
) | ||||||||||||||||||
Commercial collateralized mortgage obligations
|
|
|
(
|
)
|
|
|||||||||||||||
Asset-backed and other amortizing securities
|
|
|
(
|
)
|
|
|||||||||||||||
Other securities
|
|
|
(
|
)
|
|
|||||||||||||||
$
|
|
$
|
|
$
|
(
|
)
|
$ |
$
|
|
Available for Sale
|
||||||||
Amortized
Cost
|
Fair
Value
|
|||||||
Within 1 year
|
$
|
|
$
|
|
||||
After 1 year through 5 years
|
|
|
||||||
After 5 years through 10 years
|
|
|
||||||
After 10 years
|
|
|
||||||
Declining-balance securities
|
|
|
||||||
$
|
|
$
|
|
Less than 12 Months
|
12 Months or More
|
Total
|
||||||||||||||||||||||
Fair
Value
|
Unrealized
Loss
|
Fair
Value
|
Unrealized
Loss
|
Fair
Value
|
Unrealized
Loss
|
|||||||||||||||||||
March 31, 2024
|
||||||||||||||||||||||||
State and municipal
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Residential mortgage-backed securities
|
||||||||||||||||||||||||
Commercial mortgage-backed securities
|
||||||||||||||||||||||||
Commercial collateralized mortgage obligations
|
|
|
|
|
|
|
||||||||||||||||||
Asset-backed and other amortizing securities
|
|
|
|
|
|
|
||||||||||||||||||
Other securities
|
|
|
|
|
|
|
||||||||||||||||||
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
December 31, 2023
|
||||||||||||||||||||||||
State and municipal
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Residential mortgage-backed securities
|
||||||||||||||||||||||||
Commercial mortgage-backed securities
|
||||||||||||||||||||||||
Commercial collateralized mortgage obligations
|
|
|
|
|
|
|
||||||||||||||||||
Asset-backed and other amortizing securities
|
|
|
|
|
|
|
||||||||||||||||||
Other securities
|
|
|
|
|
|
|
||||||||||||||||||
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
March 31,
2024
|
December 31,
2023
|
|||||||
Commercial real estate
|
$
|
|
$
|
|
||||
Commercial - specialized
|
|
|
||||||
Commercial - general
|
|
|
||||||
Consumer:
|
||||||||
1-4 family residential
|
|
|
||||||
Auto loans
|
|
|
||||||
Other consumer
|
|
|
||||||
Construction
|
|
|
||||||
|
|
|||||||
Allowance for credit losses on loans
|
(
|
)
|
(
|
)
|
||||
Loans, net
|
$
|
|
$
|
|